language_icon
EN
HI

Orchid Pharma Share price

ORCHPHARMA

569.4

3.70 (0.65%)
NSE
BSE
Last updated on 17 Apr, 2026 | 15:59 IST
Today's High

577.05

Today's Low

563.10

52 Week Low

480.00

52 Week High

899.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Orchid Pharma Chart

Orchid Pharma Share Key Metrics

Volume
61239.00
Market Cap
2887.95 CR
LTQ@LTP
81@569.40
ATP
569.35
Var Margin
21.85 %
Circuit Range
452.6-678.8
Delivery %
46.27 %
Value
3.49 CR
ASM/GSM
No
Market Lot
1

Summary

Orchid Pharma share price stands at ₹569.4 at 17 Apr, 2026 | 15:59. The stock Orchid Pharma intraday movement has stayed between ₹563.10 and ₹577.05, while on a 52-week basis it has fluctuated from ₹480.00 to ₹899.00.
In terms of trading activity, Orchid Pharma has recorded a volume of 61239 shares. The Orchid Pharma has a market cap of ₹50719105. The stock’s Average Traded Price (ATP) stands at ₹56935, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 81, 56940.
The Orchid Pharma operates within a circuit range of ₹452.6-678.8 – ₹452.6-678.8, with a Value of ₹3.49 CR. The Delivery Percentage for the day is 46.27%. Additionally, Orchid Pharma currently falls under the No framework, and trades with a market lot size of 1.

Orchid Pharma Fundamentals

View More
P/E Ratio

153.36

P/B Ratio

2.29

Div. Yield

0

Sector P/E

64.78

Sector P/B

3.49

Sec. Div. Yield

0.56

Orchid Pharma Resistance and Support

Pivot 568.17

Resistance

First Resistance

579.34

Second Resistance

592.97

Third Resistance

604.14

Support

First Support

554.54

Second Support

543.37

Third Support

529.74

Orchid Pharma Shareholding Pattern

View More
  • 2019-20
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2020-21
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

26.68%

Mutual Fund

0%

Insurance

3.66%

Foreign Institutional Investors

0.8%

Domestic Institutional Investors

0.06%

Retail

68.8%

Others

0%

Total Promoters
MAR '18
26.69%
JUN '18
26.68%
SEP '18
26.68%
DEC '18
26.68%

Orchid Pharma Corporate Actions

DateAgenda
2026-02-11Quarterly Results
2025-11-11Quarterly Results
2025-08-12Quarterly Results
2025-05-26Audited Results
2025-02-12Quarterly Results

Orchid Pharma News

Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30

NCLT Chennai Bench dismissed DBS Bank's interim application against Orchid Pharma claiming lease rent during the CIRP period. This removes a potential financial liability for the company.
Apr 11 2026 17:04:00

Orchid Pharma Limited

NCLT Chennai Bench dismissed DBS Bank's application against Orchid Pharma regarding lease rent claims during the CIRP period. This order, dated April 2, 2026, confirmed no financial impact on the company.
Apr 11 2026 17:04:00

Orchid Pharma Ltd - 524372 - Investor Roadshow Scheduled To Be Held On April 10, 2026.

Orchid Pharma's Whole Time Director, Mr. Mridul Dhanuka, will participate in an investor roadshow on April 10, 2026. The group meet, held physically in Gurugram, will not involve sharing any unpublished price sensitive information.
Apr 07 2026 18:04:00

Orchid Pharma Limited

Orchid Pharma to conduct an investor roadshow on April 10, 2026, in Gurugram. Whole Time Director Mr. Mridul Dhanuka will participate, and no unpublished price sensitive information will be shared.
Apr 07 2026 18:04:00

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating

Orchid Pharma's long-term bank facilities downgraded to CARE BBB+ (Stable) from CARE A-. The rating action by CARE Ratings Limited affects total facilities of ₹366.50 crore and includes reaffirmation of short-term ratings.
Apr 02 2026 15:04:00

Orchid Pharma Limited

Orchid Pharma's long-term bank facilities rating downgraded by CARE Ratings from CARE A- to CARE BBB+ (stable outlook). This impacts facilities worth ₹366.50 crore, reflecting a revised assessment of the company's financial position.
Apr 02 2026 15:04:00
Read More

About Orchid Pharma

NSE : 926  
BSE : 524372  
ISIN : INE191A01027  

Orchid Chemicals & Pharmaceuticals Limited (ORCHID) as incorporated as a Public Limited Company on July 01 1992 under the Companies Act 1956. The Company obtained Certificate of Commencement of Business on October 15 1992. ORCHID has its registered office at Madras ORCHID hasset up a 100% Export Oriented Unit for the manufacture of 7 ADCA (intermediate) Cephalexin Cefradine and Cefadroxyl bulk drugs at a cost of Rs.1195 lakhs in technical and financial collaboration with Sintofarm SPA Italy. This unit is located at SIDCO Pharmaceutical Zone Alathur Tamilnadu. The Project was completed two months ahead ofschedule and after successful trial runs in Jan-94 commercial operations commenced from Feb. 94. In Feb 94 ORCHID undertook a Scheme at a cost of Rs.160 lakhs for better recovery of solvents backward integration and process optimization. During its first two months of operations the Company''s unit achieved a capacity utilization of 80% and produced 12.1 tonnes of Cephalexin out of which 11.7 tonnes (97%) was exported.The products are exported to Germany Italy Switzerland Holland Spain Cyprus Hongkong Singapore etc. and have been well received in the International Markets resulting in repeat orders.

Read More

Orchid Pharma Management

NamePosition
View More

Orchid Pharma FAQs

The Buying Price of Orchid Pharma share is 569.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 153.36. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Orchid Pharma shares is 2.29. Useful to assess the stock's value relative to its book value.

To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 64.78 & 3.49 with sector averages, along with growth rates and financial metrics.

The Market Cap of Orchid Pharma is 2887.95 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Orchid Pharma share price is 899.00 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Orchid Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost